Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEXX Laboratories, Inc. - Common Stock (NQ:IDXX)

628.75 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IDEXX Laboratories, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 15 Years
 
Via Benzinga
Where IDEXX Laboratories Stands With Analysts
 
Via Benzinga
Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?
Wall Street ends week on negative note as traders revise down expectations on Fed rate cuts. Strong economic data and Fed officials' comments push stocks into red, reducing rate cut expectations for... 
Via Benzinga
Topics Economy
Why Is Animal Diagnostic-Focused IDEXX Laboratories Stock Trading Higher Today?
IDEXX Laboratories gains on Q4 2023 results. Despite challenges, Idexx demonstrates resilience in the global animal health market. 
Via Benzinga
IDEXX Laboratories Earnings Preview
 
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss IDEXX Laboratories Stock
 
Via Benzinga
P/E Ratio Insights for IDEXX Laboratories
 
Via Benzinga
(IDXX) - Analyzing IDEXX Laboratories's Short Interest
 
Via Benzinga
IDEXX Announces Fourth Quarter and Full Year Results
From IDEXX Laboratories, Inc.
Via Business Wire
Earnings Scheduled For February 5, 2024
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is estimated to report quarterly earnings at $0.26 per share on revenue of $43.92 million. 
Via Benzinga
$1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $1,000 Today
 
Via Benzinga
Examining the Quality Attributes of NASDAQ:IDXX.
Why Quality-Oriented Investors Should Consider NASDAQ:IDXX. 
Via Chartmill
IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
3 Purrfect Stocks to Buy for the Booming Pet Care Industry
Despite the post-pandemic slowdown, stocks within the pet care industry are good long-term investments because the revenue trend is higher. 
Via InvestorPlace
Stifel: ‘Party Is Just Getting Started’ In This Stock That's Up 80%
Animal-pharma company Elanco Animal Health, once a subsidiary of Lilly, looks especially good with its new treatment for parvovirus in dogs. 
Via Talk Markets
(IDXX) - Analyzing IDEXX Laboratories's Short Interest
 
Via Benzinga
IDEXX Laboratories Schedules Two Institutional Investor Events
From IDEXX Laboratories, Inc.
Via Business Wire
$1000 Invested In This Stock 10 Years Ago Would Be Worth $10,000 Today
 
Via Benzinga
IDEXX Laboratories Inc. (NASDAQ: IDXX) is a Leading Gainer in Monday Morning Trading
Via Investor Brand Network
IDEXX Laboratories Stock Earns IBD Stock Rating Upgrade
On Wednesday, IDEXX Laboratories now stock clears the 80-plus Relative Strength Rating threshold, with a jump from 79 to 83. 
Via Investor's Business Daily
PROCEPT BioRobotics Stock Scores Rising Relative Strength
The Relative Strength (RS) Rating for PROCEPT BioRobotics stock headed into a new percentile Tuesday, as it got a lift from 70 to 77. 
Via Investor's Business Daily
SAIC Reports Q3 Results, Joins Uber, Wallbox And Other Big Stocks Moving Higher On Monday
U.S. stocks traded lower, with the Dow Jones index falling more than 100 points on Monday. 
Via Benzinga
Topics Stocks
Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today
 
Via Benzinga
Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today
 
Via Benzinga
How Is The Market Feeling About IDEXX Laboratories?
 
Via Benzinga
5 Analysts Have This to Say About IDEXX Laboratories
 
Via Benzinga
IDEXX Laboratories's Earnings: A Preview
 
Via Benzinga
Is There An Opportunity To Buy IDEXX Labs, The Animal Diagnostics-Focused Firm Stock After Q3 Performance? Analyst Answers
IDEXX Laboratories Inc (NASDAQ: IDXX) reported Q3 FY23 sales of $915.53 million, missing the consensus of $926.76 million 
Via Benzinga
IDEXX Laboratories Announces Third Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.